Fantastic News!
Instat is now a part of Veristat. Read the press release.

Mark McBride, PhD CEO, Co-founder

Mark McBride serves as Partner at Instat. He has more than 25 years’ experience in leadership and management of biostatistics and data management services in the pharmaceutical and biotechnology industry. He specializes in combining strong technical knowledge with customer-focused results. Mark consistently focuses on his clients and helps Instat provide its services with the most positive customer experience in mind.

Prior to co-founding Instat, Mark enjoyed a successful career with a leading CRO where he held a variety of senior management positions, including Senior Vice President, Global Biostatistics and Data Management. Mark received his PhD in Biostatistics from the University of North Carolina.

Meet Virtually Call Email

Kyle McBride CEO, Co-founder

Kyle McBride, Partner at Instat and experienced Biostatistician and innovative Statistical Programmer, has served in the clinical research industry for more than 20 years across many therapeutic areas. Kyle specializes in streamlining and increasing reliability of statistical business processes, and utilizing SAS and other technologies. He developed the proprietary SAS-based, macro-driven statistical programming platform used for all projects, enabling agility and superior quality for Instat’s biostatistics services.

Prior to co-founding Instat, Kyle served as the Director of Data Technologies at a leading CRO. While there, he implemented new technology solutions supporting biostatistics and data management. Additionally, he has many years in various management positions in Biostatistics, Data Management and Information Technology. Kyle received his MS in Biostatistics from Rutgers University.

Meet Virtually Call Email

David Koster CEO, Co-founder

David Koster, Partner at Instat, has a proven record of customer satisfaction throughout his career. His specialty is providing high-quality services in support of biostatistical elements of drug development with an emphasis on the regulatory components necessary for drug approval, including direct interaction with the FDA. He has extensive experience navigating through the complex statistical considerations necessary for the regulatory submission process. He accomplishes this with calm confidence and consistently delivering quality, timely statistical results and necessary deliverables.

Prior to co-founding Instat, David served as Director of Biostatistics at a leading CRO. He has also held various management positions in Biostatistics and led several biostatistics projects with many resulting in successful regulatory submissions. David received his MS in Biostatistics from Rutgers University.

Meet Virtually Call Email
Get in touch with our leadership
We're available to answer your questions
Ask Me